On September 20th, Professor Li Baosheng, the director of the Chinese Medical Association's Oncology Radiotherapy Branch and the deputy director of Shandong Cancer Hospital, visited Zhongjiu Flash Medical Technology Co., Ltd. (hereinafter referred to as "Zhongjiu Flash"), a subsidiary of Changhong Holding Group, in Mianyang. Yang Jun, the deputy secretary of the Party Committee and general manager of Changhong Holding Group, accompanied him on the visit.

As an authoritative expert in China's oncology radiotherapy field, Professor Li Baosheng conducted an in-depth investigation into the company's innovative practices in the research and development of FLASH radiotherapy equipment and its clinical transformation. He also engaged in an in-depth exchange with the Zhongjiu Flash team regarding the implementation of technology and its clinical application.

In the Changhong Zhongjiu Flash FLASH laboratory exhibition hall, General Manager He Xintan gave a detailed report to Professor Li Baosheng on the development process, phased breakthroughs, and product registration and marketing plans of the new generation of FLASH radiotherapy equipment. After listening to the report, Professor Li Baosheng affirmed the "FLASH speed" growth of Zhongjiu Flash. Focusing on the key links of the equipment's clinical transformation, he put forward highly targeted suggestions based on his many years of clinical experience and industry insights.

Subsequently, Professor Li Baosheng visited the experimental platform for FLASH and conventional linear accelerator comparative experiments and the testing area for two FLASH radiotherapy equipment engineering prototypes. He said, "The practice of Changhong Zhongjiu Flash has shown me the 'new possibilities' of domestic high-end medical equipment - with technological innovation as the engine, clinical needs as the guide, and industrial collaboration as the support, this path will surely become wider and wider."

Yang Jun expressed his gratitude for Professor Li Baosheng's visit and earnestly requested that Director Li, from an expert's perspective, provide guidance for Zhongjiu Flash's research and transformation. He also called for more experts in the field to jointly promote the accelerated clinical application of FLASH radiotherapy technology, benefiting more cancer patients.